The gene for this molecule was reported to be amplified in 2–10% of human breast tumors and the protein overexpressed in 30–60% of tumors, suggesting that RAC3 provides a growth advantage for breast cancer cells [44]. The gene discussed is RAC3; the disease is breast neoplasm.